E-mail: info@almedis.ru
Tel: +7 495 937 43 18
Fax: +7 495 937 43 19
Address: 5, Ulitsa Malaya Pirogovskaya, office 22
119435 Moscow, Russia

RUS ENG
About Us
Our Services
Quality
Contact Us
News
Links
Career

ALMEDIS is an independent contract research organization (CRO) with operations all over Russia

ALMEDIS provides comprehensive range of services in international and local clinical trials, observational studies, data management, biostatistics, medical writing and training programs.

Our CRO is committed to meeting the needs and expectations of our clients by providing professional and superior quality service, with integrity, reliability and strong client focus.

ALMEDIS is a member of the Association of Clinical Trial Organizations (ACTO).

    ALMEDIS is an Effective Resource for:
  • International pharmaceutical companies
  • International contract research organizations (CROs)
  • Pharmaceutical and biotech companies launching their clinical research activities in Russia
  • Scientific research organizations

Since 2007 ALMEDIS team has successfully managed more than 100 projects, including international and local Phase II - IV clinical trials and observational studies.

    Latest News:

  • ALMEDIS has performed one-day training “Using of PRO and Health Measurement Scales in Clinical Trials” for a corporate client
  • 200 recruited patients have been recruited in Russia in an international multicenter Phase III trial in patients with acute coronary syndrome receiving antiplatelet therapy after pharmacological thrombolysis
  • ALMEDIS has received an approval of the Ministry of Health of Russia for a Phase II clinical trial of a combination of antiviral drugs in treatment-naïve patients with chronic hepatitis C
  • LPLV milestone has been achieved in the Extension Phase of an international multicenter Phase III clinical trial in patients with chronic hepatitis C
  • Study Protocol has been prepared for a non-interventional study in patients with type 2 diabetes mellitus.

 



ALMEDIS is solely responsible for this site content. This information is intended for use by our customers and clinical research specialists.
© 2006-2016 ALMEDIS All rights reserved